Therapy-related pro-B cell acute lymphoblastic leukemia: Report of two patients with MLL amplification

Cancer Genetics

Volumn 205, Issue 12, 2012, Pages 653-656

  Racke, Frederick ^a   Cole, Carol ^a   Walker, Alison ^a   Jones, Jeffrey ^a   Heerema, Nyla A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

MLL amplification; Therapy related ALL

Indexed keywords

CARBOPLATIN; CD19 ANTIGEN; CD34 ANTIGEN; CD79A ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; ETOPOSIDE; HLA DR ANTIGEN; IFOSFAMIDE; MICROSOMAL AMINOPEPTIDASE; MIXED LINEAGE LEUKEMIA PROTEIN; ONCOPROTEIN; PROTEIN CD15; PROTEIN CD34; PROTEIN CD65; RITUXIMAB; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CELL COUNT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GINGIVA BLEEDING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOPENIA; MALE; METAPHASE; MLL GENE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RASH; SARCOMA; THROMBOCYTOPENIA;

AGED, 80 AND OVER; BONE MARROW; DRUG THERAPY; GENE AMPLIFICATION; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; STAINING AND LABELING;

EID: 84872048289     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.11.001     Document Type: Article

References (24)

1. Leone G., Pagano L., Ben-Yehuda D., et al. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007, 92:1389-1398.
2. Bagg A. Therapy-associated lymphoid proliferations. Adv Anat Pathol 2011, 18:199-205.
3. Vardiman J.W., Arber D.A., Brunning R. Acute myeloid leukemia (AML) and related precursor neoplasms. WHO Classification of Tumours of Haematopoietic Lymphoid Tissues 2008, 109-145. IARC Press, Lyon, France. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
4. Borowitz M.J., Chan J.K.C. Precursor lymphoid neoplasms. WHO Classification of Tumours of Haematopoietic Lymphoid Tissues 2008, 171-175. IARC Press, Lyon, France. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
5. Hess J.L. MLL: a histone methyltransferase disrupted in leukemia. Trends Mol Med 2004, 10:500-507.
6. Whitman S.P., Liu S., Vukosavljevic T., et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood 2005, 106:345-352.
7. Dolan M., McGlennen R.C., Hirsch B. MLL amplification in myeloid malignancies: clinical, molecular, and cytogenetic findings. Cancer Genet Cytogenet 2002, 134:93-101.
8. Andersen M.K., Christiansen D.H., Kirchhoff M., et al. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 2001, 31:33-41.
9. Andersen M.K., Christiansen D.H., Jensen B.A., et al. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001, 114:539-543.
10. Chen W., Wang E., Lu Y., et al. Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol 2010, 133:75-82.
11. Tsuboi K., Komatsu H., Miwa H., et al. T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia. Int J Hematol 2003, 77:518-521.
12. Bloomfield C.D., Archer K.J., Mrozek K., et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002, 33:362-378.
13. Abdulwahab A., Sykes J., Kamel-Reid S., et al. Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis. Cancer 2012, 118:3962-3967.
14. Pagano L., Pulsoni A., Mele L., et al. Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy. Leuk Lymphoma 2000, 39:465-475.
15. Tang G., Zuo Z., Thomas D.A., et al. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?. Haematologica 2012, 97:919-925.
16. Ishizawa S., Slovak M.L., Popplewell L., et al. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia 2003, 17:1091-1095.
17. ISCN 2009: An International System for Human Cytogenetic Nomenclature 2009, Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.).
18. Slany R.K. The molecular biology of mixed lineage leukemia. Haematologica 2009, 94:984-993.
19. Meyer C., Kowarz E., Hofmann J., et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 23:1490-1499.
20. Hess J.L. Mechanisms of transformation by MLL. Crit Rev Eukaryot Gene Expr 2004, 14:235-254.
21. Espinet B., Florensa L., Salido M., et al. MLL intrachromosomal amplification in a pre-B acute lymphoblastic leukemia. Haematologica 2003, 88:EIM03.
22. Cuthbert G., Thompson K., McCullough S., et al. MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 2000, 14:1885-1891.
23. Haltrich I., Csoka M., Kovacs G., et al. Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia. Pathol Oncol Res 2012, [Epub ahead of print].
24. Van Mater D., Goodman B.K., Wang E., et al. MLL duplication in a pediatric patient with B-cell lymphoblastic lymphoma. J Pediatr Hematol Oncol 2012, 34:e120-e123.